Skip to main content

Pakistan allows import, manufacture of Remdesivir for emergency COVID-19 use

The Drug Regulatory Authority of Pakistan has allowed the import and manufacturing of antiviral Remdesivir for severely ill COVID-19 patients, Radio Pakistan reported on Monday.

Registration letters were issued to two importers and 14 local manufacturers.

Remdesivir is an experimental antiviral drug that was invented as a potential treatment for Ebola. It has been approved for emergency use in Pakistan, according to the spokesperson of the Ministry of National Health Services.

DRAP’s registration board in its meeting held from June 8 to 11 had allowed the emergency use of Remdesivir.

The US Food and Drug Administration granted emergency use authorisation of the drug on May 1.

DRAP has only permitted health facilities treating COVID-19 patients to use the drug “in order to avoid the hoarding, profiteering and the distribution of Remdesivir through the black market, and its irrational use by healthcare professionals through private clinics.”

In an advisory for the use of Remdesivir, the regulatory body said unauthorised use by anyone other than designated public and private hospitals can be reported to the Quality Assurance and Lab Testing Division of DRAP and the provincial chief drug inspector.

Pharmaceutical companies and health facilities need to maintain a record of their Remdesivir inventory. Additionally, hospitals have to record patient information such as their biodata, disease severity and amount of Remdesivir administered to them.

The potential COVID-19 drug can only be used in children and adults if the following criteria are met: suspected or laboratory confirmed COVID-19, oxygen levels below 94% and requirement of supplemental oxygen, mechanical ventilation or extracorporeal membrane oxygenation.

Remdesivir should be given to hospitalised patients through an IV line by a healthcare provider under strict supervision of a qualified specialist, DRAP has instructed.

Serious side effects can be reported to the Pakistan National Pharmacovigilance Centre, through DRAP Med Vigilance e-reporting system: https://primaryreporting.whoumc.org/Reporting/Reporter?OrganizationID=PK, or via email to npc@dra.gov.pk.

DRAP has listed the following side effects: increased levels of liver enzymes due to inflammation in the liver and infusion-related reactions including low blood pressure, nausea, vomiting, sweating and shivering.



from SAMAA https://ift.tt/2Nh8FwW
Labels:

Comments

Post a Comment

Popular posts from this blog

Trump says he urged team to ‘slow’ COVID-19 testing

US President Donald Trump said Saturday he was encouraging health officials in his administration to slow down coronavirus testing, arguing that increased tests lead to more cases being discovered. The president has claimed falsely on several occasions that surges of COVID-19 in several states can be explained by greater numbers of diagnostic tests. At his first rally since the outbreak forced nationwide shutdowns in March, Trump told the crowd in Tulsa, Oklahoma that testing was a “double-edged sword.” The United States — which has more deaths and cases than any other country — has carried out more than 25 million coronavirus tests, placing it outside the top 20 countries in the world, per capita. “Here is the bad part: When you do testing to that extent, you are going to find more people, you will find more cases,” Trump argued. “So I said to my people ‘slow the testing down.’ They test and they test.” It was not clear from Trump’s tone if he was playing to the crowd, who ...
Post a Comment
Read more

Rouhani calls Imran, discusses resumption of trade

ISLAMABAD: Pakistan and Iran on Wednesday discussed full resumption of bilateral trade, which was halted last month because of the Covid-19 pandemic. “The two sides stressed the need to reactivate borders and border markets and strengthen trade ties by following health guidelines,” a statement issued by the Iranian presidency on the telephonic conversation between Prime Minister Imran Khan and President Dr Hassan Rouhani said. President Rouhani had called the prime minister for Ramazan greetings. Border trade between the two countries was suspended after a meeting of the National Security Committee (NSC), held on March 13, decided to close all borders because of the pandemic. Islamabad partially relaxed the restrictions on April 21, allowing the import of certain food items and provision of petrol and diesel to the border areas. Cargo traffic from Iran was allowed for three days every week. Cargo movement between the two countries takes place through five border crossings — Taftan...
Post a Comment
Read more

Today’s outlook: Sindh CM discusses reopening markets with PM Khan

Here are some of the stories we are expecting to follow today (Thursday): Sindh Chief Minister Murad Ali Shah will take Prime Minister Imran Khan into confidence over reopening shops and markets across the province. The reopened markets will have to follow SOPs. Sindh Transport Minister Awais Qadir Shah will discuss SOPs with transporters for resuming public transport in the coming days. The meeting will be held at the Sindh Assembly building at 1:30pm. The Oil and Gas Regulatory Authority has proposed a price cut of Rs20.68 per litre for petrol in its summary. Imam-e-Kaaba Sheikh Abdul Rahman Al-Sudais has said Masjid Al Haram and Masjid Al Nabawi will be reopened for worshipers soon. He said the Kaaba is being sterilised using latest technologies. Punjab Chief Minister Usman Buzdar will head various meetings during his visit to Bahawalpur. As of Thursday, Pakistan has reported more than 15,500 confirmed coronavirus cases. ICYMI: An amendment to the National Accountability Or...
Post a Comment
Read more